Joint effect of insulin-Like growth factors and mutagen sensitivity in lung cancer risk

Growth Hormone and IGF Research

Volumn 10, Issue SUPPL. A, 2000, Pages

  Wu, X ^a   Yu, H ^a   Amos, C I ^a   Hong, W K ^a   Spitz, M R ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZO[A]PYRENE DERIVATIVE; BLEOMYCIN; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

CANCER EPIDEMIOLOGY; CANCER RISK; CELL PROLIFERATION; CONFERENCE PAPER; GENETIC SUSCEPTIBILITY; HUMAN; LUNG CANCER; MUTAGENESIS; PRIORITY JOURNAL; RISK FACTOR;

EID: 0033903444     PISSN: 10966374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1096-6374(00)90012-1     Document Type: Conference Paper

References (7)

1. Insulin-like growth factor I is a growth and survival factor in human mutiple myeloma cell lines
2. Endocrine effects of IGF-I on normal and transformed breast epithelial cells: Potential relevance to strategies for breast cancer treatment and prevention
3. Insulin-like growth factor (IGF) system components in human prostatic cancer cell-lines: LNCaP, DU145, and PC-3 cells
4. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer
5. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3
6. Plasma levels of insulin-like growth factor-I and lung cancer risk: A case-control analysis
7. Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study